C4 Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

Related posts

• 10.01.2022

  C4 Therapeutics Announces 2022 Key Milestones to Advance Targeted Protein Degradation Portfolio

  C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced strategic priorities and 2022 milestones...

  Read More
• 05.01.2022

  Built In Honors Rightway in Its Esteemed 2022 Best Places To Work Awards

  Today, Built In announced that Rightway, the leader in cutting-edge care navigation and pharmacy benefits, was honored in its 2022 Best Places To Work Awards. Rightway placed on two lists for New York City, Best...

  Read More
• 04.01.2022

  Frequency Therapeutics to Present 2022 Business and Pipeline Overview at the 40th Annual J.P. Morgan Healthcare Conference

  Company to Review Milestones for its Phase 2b Study of FX-322, the Near-Term Clinical Plan for its Second Hearing Restoration Asset, FX-345, and Selection of a Lead Candidate for its Novel Multiple Sclerosis Program that...

  Read More